Back to Search Start Over

617O Lemzoparlimab, a differentiated anti-CD47 monoclonal antibody, in combination with azacitidine (AZA) in patients with newly diagnosed higher risk myelodysplastic syndrome (HR-MDS): Initial clinical results

Authors :
Z. Xiao
C. Chang
Q. Li
X. Yan
T. Qin
H. Tong
M. Dai
Y. He
J. Weng
J. Li
S. Gao
R. Fu
X. Wei
X. Ma
Y. Zhang
W. Huang
Q. Wang
L. Gu
Y. Meng
A. Zhu
Source :
Annals of Oncology. 33:S827
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Oncology
Hematology

Details

ISSN :
09237534
Volume :
33
Database :
OpenAIRE
Journal :
Annals of Oncology
Accession number :
edsair.doi...........4ec2e7377b97b73486d45096cd483c11
Full Text :
https://doi.org/10.1016/j.annonc.2022.07.743
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details